Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Study of variants of papillary carcinoma of Thyroid with a special emphasis on NIFTP (Non-invasive Follicular Thyroid Neoplasm with Papillary like nuclear features)

N Nirmala Jyoti, G V R N Krishna kanth

A libraries survey of different colleges of education with respect to facilities, usages and modernization: A college would be incomplete without a good library

Tarseem Kumar

Consumer’s awareness and privacy concerns regarding online behavioral advertising

Priyanka, Sadaf Siraj

Effect of stress on fertility in albino rats

K. Muthuselvi, T. Meena

Comparison of volatile agent isoflurane vs conventional methods with intermittent propofol and benzodiazepine for BIS targeted anaesthesia on cardiopulmonary bypass

Sandip W Junghare, Minakshi S Junghare, Vinayak N Desurkar, Vipul K Sharma, Anurag A Garg, Shekhar Shinde

Rare anatomical variations in lungs - A case report

Ritika Kaswa, Lakshita Sharma, Ankita Pareek, Anamika Kumari Yadav, Sandeep M Lahange, Neha Udainiya

Anatomical variations of the brachiocephalic artery and their clinical relevances: A cadaveric study of Ugandan population

Andrew Emmanuel Tito, Kebe Edet Obeten, Victor Archibong, Ekon Monday Etukudo, Joseph Atupele Mwabaleke, Ibe Michael Usman, Mario Edgar Fernandez

Emsella: A breakthrough, non invasive technology for treatment of incontinence

Juhi Deshpande, Chanchal Kumar Singh*

SWOT analysis of the Directly Observed Treatment Short-course (DOTS) strategy under the revised national tuberculosis control program at a large center in west Delhi

Sankalp Yadav, Gautam Rawal